Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Saraswanti Anugerah Makmur Tbk. (SAMF)

UBC Medical Indonesia Tbk.Trading

Saraswanti Anugerah Makmur Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Saraswanti Anugerah Makmur Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Saraswanti Anugerah Makmur Tbk. diperdagangkan di Rp276 (kapitalisasi pasar 2,91 T, volume 24 jam 35 rb). Perbedaan utamanya: Saraswanti Anugerah Makmur Tbk. jauh lebih besar — sekitar 5× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 35 rb). Mana yang lebih baik tergantung tujuan investasimu.

	LABS	SAMF
Kapitalisasi Pasar	576,7 M	2,91 T
Volume	3,48 jt	35 rb
Lot	34,82 rb	350
Perputaran	522,79 jt	9,75 jt
Harga Rata-rata	150,13	278,53
Nilai Transaksi	522,79 jt	9,75 jt
Harga Ekuilibrium Indikatif	148	—
Volume Ekuilibrium Indikatif	350	—

Lihat detail →Lihat detail →

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS

Lihat detail →

SAMF

Lihat detail →

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS →

Tentang Saraswanti Anugerah Makmur Tbk.

PT. Saraswanti Anugerah Makmur Tbk. (the Company) was established based on the Notarial Deed of Titiek Lintang Trenggonowati, S.H., No.15 dated June 18, 1998, notary in Surabaya.

Selengkapnya di halaman SAMF →